Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: Analysis of a hospital-based tumor registry

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 8, 2009, Pages 1424-1430

  Fernández Ruiz, Mario ^a,b   Guerra Vales, Juan Manuel ^a   Castelbón Fernández, Francisco Javier ^a   Llenas García, Jara ^a   Caurcel Díaz, Luis ^a   Colina Ruizdelgado, Francisco ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Hospital Tumor Registry University Hospital '12 de Octubre' Universidad Complutense ^*  (Spain)

Author keywords

Extrahepatic; Hepatocellular carcinoma; Multiple primary neoplasms; Prognosis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER REGISTRY; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HISTORY; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION TEST; LUNG CARCINOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE CANCER; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL; UROGENITAL TRACT CANCER;

EID: 69049118159     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05793.x     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. C.A. Cancer J. Clin. 2005 55 : 74 108.
2. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004 127 (Suppl. 1) S27 34.
3. Shimada M, Takenaka K, Fujiwara Y et al. Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan. Am. J. Gastroenterol. 1996 91 : 754 758.
4. Kanematsu M, Imaeda T, Yamawaki Y et al. Hepatocellular carcinoma with extrahepatic primary neoplasms. Gastrointest. Radiol. 1992 17 : 53 7.
5. Takayasu K, Kasugai H, Ikeya S et al. A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer. Cancer 1992 69 : 45 51.
6. Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am. J. Clin. Oncol. 2003 26 : 79 83.
7. Warren S, Gates O. Multiple primary malignant tumors. A survey of the literature and statistical study. Am. J. Cancer 1932 16 : 1358 1364.
8. Nzeako UC, Goodman ZD, Ishak KG. Association of hepatocellular carcinoma in North American patients with extrahepatic primary malignancies. Cancer 1994 74 : 2765 2771.
9. Riesz T, Jákó JM, Juhász J. Secondary malignant tumors accompanied by primary hepatocellular carcinoma. Acta Hepatogastroenterol (Stuttg). 1979 26 : 364 367.
10. Lin DY, Liaw YF, Wu CS, Chang-Chien CS, Chen PC, Chen TJ. Hepatocellular carcinoma associated with second primary malignancy. Liver 1987 7 : 106 109.
11. Lai CR, Liu HC. Hepatocellular carcinoma coexisted with second malignancy: a study of 13 cases from a consecutive 440 autopsy cases of HCC. Zhonghua Yi Xue Za Zhi (Taipei) 1990 46 : 202 207.
12. Di Stasi M, Sbolli G, Fornari F et al. Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors. Oncology 1994 51 : 459 464.
13. Onitsuka A, Hirose H, Ozeki Y, Hino A, Senga S, Iida T. Clinical study on hepatocellular carcinoma with extrahepatic malignancies. Int. Surg. 1995 80 : 128 130.
14. Pangher Manzini V, Calucci F, Terpin MM et al. Multiple primary malignant tumors in patients with hepatocellular carcinoma. A review of 29 patients. Tumori 1996 82 : 245 248.
15. Chen CN, Lee PH, Lee WJ, Chang KJ, Chen KM. Synchronous hepatocellular carcinoma or metastatic hepatic tumor with primary gastric cancer. Hepatogastroenterology 1998 45 : 492 495.
16. Bruno G, Andreozzi P, Graf U, Santangelo G. Hepatitis C virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction? Clin. Ter. 1999 150 : 413 418.
17. Koide N, Hanazaki K, Fujimori Y et al. Synchronous gastric cancer associated with hepatocellular carcinoma: a study of 10 patients. Hepatogastroenterology 1999 46 : 3008 3014.
18. Minni F, Casadei R, Marrano N et al. [Second tumors in patients with malignant neoplasms of the digestive apparatus. A retrospective study on 2406 cases.]. Ann. Ital. Chir. 2005 76 : 467 472 (in Italian).
19. Wong LL, Lurie F, Takanishi DM. Other primary neoplasms in patients with hepatocellular cancer: prognostic implications? Hawaii Med. J. 2007 66 : 206 208.
20. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004 127 (Suppl. 1) S5 16.
21. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001 35 : 421 430.
22. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 1999 19 : 329 338.
23. Carbone PP, Kaplan HS, Mushoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971 31 : 1860 1861.
24. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leucemia. Blood 1975 46 : 219 234.
25. Sankila R, Pukkala E, Teppo L. Risk of subsequent malignant neoplasms among 470 000 cancer patients in Finland, 1953-1991. Int. J. Cancer 1995 60 : 464 470.
26. Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol. Biomarkers Prev. 2007 16 : 566 571.
27. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007 12 : 20.
28. Hospital Tumor Registry. [Report of the five-year period 1999-2003.] University Hospital '12 de Octubre', 2005.
29. López-Abente G, Pollán M, Aragonés N et al. [State of cancer in Spain: incidence.] An. Sist. Sanit. Navar. 2004 27 : 165 173.
30. Sanchez EQ, Marubashi S, Jung G et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl. 2002 8 : 285 291.
31. Martins A, Cortez-Pinto H, Marques-Vidal P et al. Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int. 2006 26 : 680 687.
32. Pascual S, Zapater P, Such J et al. Comparison of staging systems to predict survival in hepatocellular carcinoma. Liver Int. 2006 26 : 673 679.
33. Suriawinata A, Thung SN. Hepatitis C virus and malignancy. Hepatol. Res. 2007 37 : 397 401.
34. Himoto T, Miyauchi Y, Nomura K et al. Coexistence of splenic non-Hodgkin's lymphoma with hepatocellular carcinoma in a patient with chronic hepatitis C. Dig. Dis. Sci. 2006 51 : 70 6.
35. Monarca R, Montanaro M, Stroffolini T. Simultaneous occurrence of hepatocellular carcinoma and low grade non-Hodgkin's lymphoma in a chronic hepatitis B surface antigen carrier. Ann. Hematol 1999 78 : 531.
36. Kumagai Y, Kawano T, Nakajima Y et al. Multiple primary cancers associated with esophageal carcinoma. Surg. Today 2001 31 : 872 876.
37. Brock MV, Alberg AJ, Hooker CM et al. Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies. J. Thorac. Cardiovasc. Surg. 2004 127 : 1119 1125.
38. Infante M, Lutman FR, Cavuto S et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 2008 59 : 355 363.
39. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2008 149 : 185 191.